Hsp90 inhibitor NVP-AUY922 enhances the radiation sensitivity of lung cancer cell lines with acquired resistance to EGFR-tyrosine kinase inhibitors

Publisher： Spandidos Publications

E-ISSN： 1791-2431|33|3|1499-1504

ISSN： 1021-335X

Source： Oncology Reports, Vol.33, Iss.3, 2015-01, pp. : 1499-1504

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiproliferative effect of the HSP90 inhibitor NVP-AUY922 is determined by the expression of PTEN in esophageal cancer

By                    

Oncology Reports, Vol. 29, Iss. 1, 2013-01 ,pp. : 45-50

Spandidos Publications

Access to resources Recommend Favorite

Usefulness of plasma HGF level for monitoring acquired resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer

By  

Oncology Reports, Vol. 33, Iss. 1, 2015-01 ,pp. : 391-396

Spandidos Publications

Access to resources Recommend Favorite

Primary and Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer: An Update

By Ayoola Ayodele   Barochia Amit   Belani Kiran   Belani Chandra P.  

Cancer Investigation, Vol. 30, Iss. 5, 2012-05 ,pp. : 433-446

Informa Healthcare

Access to resources Recommend Favorite

EGFR–tyrosine kinase mutation testing methods in non-small-cell lung cancer: new diagnostic guidance is NICE

By Wallace Andrew  

Lung Cancer Management, Vol. 2, Iss. 6, 2013-12 ,pp. : 449-451

Future Medicine

Access to resources Recommend Favorite

Potent antitumor activity of the novel HSP90 inhibitors AUY922 and HSP990 in neuroendocrine carcinoid cells

By                

International Journal of Oncology, Vol. 43, Iss. 6, 2013-01 ,pp. : 1824-1832

Spandidos Publications

Access to resources Recommend Favorite